膜联蛋白A1(ANXA1)检测试剂盒(化学发光免疫分析法)
CLIA Kit for Annexin A1 (ANXA1)
ANX-A1; ANX1; LPC1; Lipocortin I; Chromobindin-9; Calpactin II; Phospholipase A2 inhibitory protein
- 编号SCE787Hu
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 实验方法双抗夹心
- 反应时长2h, 40min
- 检测范围0.27-200ng/mL
- 灵敏度最小可检测剂量小于等于0.12ng/mL.
- 样本类型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下载 英文说明书 中文说明书
- 规格 48T96T 96T*5 96T*10 96T*100
- 价格 ¥ 3528 ¥ 5040 ¥ 22680 ¥ 42840 ¥ 352800
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
本试剂盒用于检测膜联蛋白A1(ANXA1),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
回收率
分别于定值血清及血浆样本中加入一定量的膜联蛋白A1(ANXA1)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
样本 | 回收率范围(%) | 平均回收率(%) |
serum(n=5) | 85-103 | 89 |
EDTA plasma(n=5) | 93-104 | 101 |
heparin plasma(n=5) | 91-101 | 96 |
精密度
精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%
线性
在定值血清及血浆样本内加入适量的膜联蛋白A1(ANXA1),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中膜联蛋白A1(ANXA1)含量的测定值与理论值的比率。
样本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 96-103% | 97-105% | 90-99% | 87-96% |
EDTA plasma(n=5) | 93-101% | 78-98% | 82-98% | 93-102% |
heparin plasma(n=5) | 91-98% | 78-93% | 79-102% | 93-101% |
稳定性
经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
实验流程
1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100μL,37°C孵育1小时;
4. 洗板3次;
5. 加检测溶液B100µL,37°C孵育30分钟;
6. 洗板5次;
7. 加底物100µL,37°C孵育10分钟;
8. 读数。
实验原理
将膜联蛋白A1(ANXA1)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的膜联蛋白A1(ANXA1)与连接于固相载体上的抗体结合,然后加入生物素化的膜联蛋白A1(ANXA1)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入底物。加入底物后会产生辉光型光信号。发射光强度和样品中的膜联蛋白A1(ANXA1)呈正相关。用化学发光仪测定相对光单位(RLU),计算样品浓度。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
APE787Hu01 | 膜联蛋白A1(ANXA1)活性蛋白 | Cell culture; Activity Assays. |
RPE787Hu01 | 膜联蛋白A1(ANXA1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAE787Hu01 | 膜联蛋白A1(ANXA1)多克隆抗体 | WB; IHC; ICC; IP. |
PAE787Hu02 | 膜联蛋白A1(ANXA1)多克隆抗体 | WB; IHC; ICC; IP. |
LAE787Hu81 | 膜联蛋白A1(ANXA1)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
LAE787Hu71 | 膜联蛋白A1(ANXA1)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAE787Hu22 | 膜联蛋白A1(ANXA1)单克隆抗体 | WB |
MAE787Hu21 | 膜联蛋白A1(ANXA1)单克隆抗体 | WB; IHC; ICC; IP. |
SEE787Hu | 膜联蛋白A1(ANXA1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AEE787Hu | 抗膜联蛋白A1抗体(Anti-ANXA1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
SCE787Hu | 膜联蛋白A1(ANXA1)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LME787Hu | 膜联蛋白A1(ANXA1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
KSE787Hu01 | 膜联蛋白A1(ANXA1)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
杂志 | 参考文献 |
Plos one | Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease [PubMed: PMC3794972] |
African Journals Online | Modulatory Effect of Phytoestrogens and Curcumin on Induction of Annexin 1 in Human Peripheral Blood Mononuclear Cells and their Inhibitory Effect on Secretory Phospholipase A2 [Ajol: Source] |
Antimicrobial Agents and Chemotherapy | Host Biomarkers of Invasive Pulmonary Aspergillosis to Monitor Therapeutic Response [Asm: Source] |
J Proteomics | Characterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC) [PubMed: 26718731] |
Diabetes | Annexin A1 Is a Key Modulator of Mesenchymal Stromal Cell–Mediated Improvements in Islet Function [PubMed: 26470781] |
PLoS One | Annexin A1 Is Increased in the Plasma of Preeclamptic Women [PubMed: 26398190] |
中国现代医学杂志 China Journal of Modern Medicine | 膜联蛋白A1 和CA19-9 在胆管癌中的表达及其临床意义 [article:8686] |
arteriosclerosis thrombosis and vascular biology | Protective Aptitude of Annexin A1 in Arterial Neointima Formation in Atherosclerosis-Prone Mice-Brief Report. [pubmed:28062503] |
Clinical Science | Mesenchymal stromal cells improve human islet function through released products and extracellular matrix. [pubmed:29101297] |
Biomedicine & Pharmacotherapy | Proresolving protein Annexin A1: The role in type 2 diabetes mellitus and obesity [Pubmed:29677533] |
International Journal of Chronic Obstructive Pulmonary Disease | Annexin A1 is elevated in patients with COPD and affects lung fibroblast function [Pubmed:29440885] |
Medical Mycology | Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients [Pubmed:29370415] |
DEVELOPMENTAL NEUROPSYCHOLOGY | EFFECTS OF MULTICOMPONENT EXERCISE ON PROGRESSION OF BRAIN ATROPHY AND COGNITION IN AMNESTIC MILD COGNITIVE IMPAIRMENT … [pdf:3395] |
Multiple sclerosis and related disorders | Resolution of inflammation in neuromyelitis optica spectrum disorders [Pubmed: 30300851] |
Acta Pharmaceutica | Effects of annexin A1 on apoptosis and cell cycle arrest in human leukemic cell lines [] |
npj Science of Food | Annexin A1 accounts for an anti-inflammatory binding target of sesamin metabolites [Pubmed: 32133417] |
FASEB JOURNAL | ANXA1 directs Schwann cells proliferation and migration to accelerate nerve regeneration through the FPR2/AMPK pathway [Pubmed: 32908567] |
Rev Soc Bras Med Trop | Expression of annexin-A1 in blood and tissue leukocytes of leprosy patients [33263684] |
science advances | Annexin-A1 SUMOylation regulates microglial polarization after cerebral ischemia by modulating IKK¦Á stability via selective autophagy [33523920] |